Andrew Hykes - Jan 1, 2025 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Role
President and CEO, Director
Signature
/s/ Shannon Trevino, attorney-in-fact for Andrew Hykes
Stock symbol
NARI
Transactions as of
Jan 1, 2025
Transactions value $
-$225,079
Form type
4
Date filed
1/3/2025, 04:51 PM
Previous filing
Dec 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Tax liability -$26K -509 -0.12% $51.05 439K Jan 1, 2025 Direct F1
transaction NARI Common Stock Tax liability -$48.4K -949 -0.22% $51.05 438K Jan 1, 2025 Direct F2
transaction NARI Common Stock Tax liability -$83.3K -1.63K -0.37% $51.05 436K Jan 1, 2025 Direct F3
transaction NARI Common Stock Tax liability -$67.3K -1.32K -0.3% $51.05 435K Jan 1, 2025 Direct F4
holding NARI Common Stock 1.55K Jan 1, 2025 By Child 1
holding NARI Common Stock 1.55K Jan 1, 2025 By Child 2
holding NARI Common Stock 1.55K Jan 1, 2025 By Child 3
holding NARI Common Stock 1K Jan 1, 2025 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021.
F2 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022.
F3 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023.
F4 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2024.